Portfolio company
Cogniguard
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-invasive vagus nerve stimulation medical devices to treat patients with Alzheimer's disease and mild cognitive impairment.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
Sinaptica Therapeutics
The company develops non-invasive neuromodulation systems for Alzheimer's patients to slow cognitive decline using personalized brain stimulation technology.
Leucadia Therapeutics
This company develops an implantable medical device to restore cerebrospinal fluid flow for patients with Alzheimer's disease and mild cognitive impairment.
Applied Cognition
The company develops non-invasive glymphatic system monitoring platforms and drug therapies for patients with neurological disorders like Alzheimer's and Parkinson's.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
Nuuron
This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.
